Mircette is a low‑dose combined oral contraceptive pill that contains desogestrel (0.15 mg) and ethinyl estradiol (0.02 mg) in a unique 28‑day pack: 21 active tablets, 2 reminder (inactive) tablets, and 5 tablets with very low‑dose ethinyl estradiol (10 mcg). It’s used to prevent pregnancy and to improve cycle control, often reducing cramps, flow, and breakthrough bleeding. Though the Mircette brand has been discontinued in some markets, FDA‑approved generics such as Kariva, Viorele, and Azurette use the same formulation and regimen. Always consult a clinician to confirm suitability based on your health history and medications.
Mircette is a combined oral contraceptive (COC) that prevents pregnancy primarily by suppressing ovulation. Its two hormones—desogestrel (a progestin) and ethinyl estradiol (an estrogen)—also thicken cervical mucus to hinder sperm movement and thin the uterine lining to reduce implantation likelihood. The 21/2/5 design delivers 21 standard active tablets, 2 placebo reminders, and 5 very low‑dose estrogen tablets to provide a smoother hormone transition, which may lessen hormone‑withdrawal headaches and spotting for some users.
Beyond contraception, Mircette and its AB‑rated generics (Kariva, Azurette, Viorele) are commonly used to regulate periods, decrease menstrual cramps and flow, reduce mid‑cycle pain, and treat or improve acne in some patients. It does not protect against sexually transmitted infections (STIs); consistent condom use is recommended for STI prevention. Effectiveness improves with perfect use; typical‑use failure rates of COCs are about 7% per year, largely due to missed pills.
Each Mircette cycle consists of 28 consecutive days: take 1 tablet by mouth at the same time daily. The pack contains 21 pink (or colored) active pills with 0.15 mg desogestrel/0.02 mg ethinyl estradiol, followed by 2 white inert tablets, then 5 light‑colored tablets with 10 mcg ethinyl estradiol. Start on day 1 of menstruation for immediate protection, or use the “Sunday start” or “quick start” methods with backup (condoms) for the first 7 days if you’re not starting on cycle day 1.
Swallow tablets with or without food; taking at night or with food can reduce nausea. If switching from another combined pill, begin Mircette the day after your last active pill. If switching from a progestin‑only pill, implant, IUD, or injection, timing depends on the method; use backup contraception for 7 days unless you start during the first 5 days of menstrual bleeding. Always follow your specific pack’s instructions.
Postpartum and breastfeeding: Do not start estrogen‑containing pills like Mircette until at least 3–6 weeks postpartum due to clot risk, and note that combined pills may reduce milk supply. Discuss alternatives such as progestin‑only methods if breastfeeding early postpartum or if you have elevated thrombosis risk.
Combined pills slightly increase the risk of blood clots, heart attack, and stroke—particularly in patients who smoke, are older than 35, or have other cardiovascular risk factors such as hypertension, high cholesterol, diabetes with vascular disease, or migraine with aura. Have your blood pressure checked before starting and periodically thereafter.
Alert your clinician if you have personal or family history of clotting disorders (e.g., factor V Leiden), liver disease, cholestasis, gallbladder disease, kidney disease, depression, unexplained vaginal bleeding, breast cancer or other estrogen‑sensitive cancers, or if you experience new or worsening migraines. Estrogens can elevate triglycerides and may worsen gallbladder or liver conditions in susceptible individuals.
If you smoke, particularly ≥15 cigarettes daily and are age ≥35, combined pills like Mircette are generally not recommended. Mircette does not protect against STIs; pair with condoms if STI risk is a concern. If you’re immobilized for surgery or prolonged travel, discuss temporary discontinuation due to clot risk. Stop and seek urgent care if you develop signs of serious adverse effects such as chest pain, shortness of breath, one‑sided swelling or pain in a leg, severe headache, visual changes, or slurred speech.
Do not use Mircette if you are pregnant; have ever had a blood clot (DVT/PE), stroke, or heart attack; have migraine with aura; have uncontrolled hypertension or diabetes complicated by vascular disease; have active liver disease, liver tumors, or severe cirrhosis; have current or past estrogen‑ or progestin‑sensitive cancer (e.g., breast cancer); have undiagnosed abnormal uterine bleeding; or smoke and are age ≥35. Mircette is also contraindicated in known thrombophilia, hypersensitivity to any component, and in those with certain hepatitis C regimens that contain ombitasvir/paritaprevir/ritonavir (with or without dasabuvir) due to ALT elevations.
Common side effects are usually mild and improve within 2–3 cycles: nausea, breast tenderness, spotting or breakthrough bleeding (especially early), headache, mood changes, bloating, and changes in libido. Some users notice lighter, more predictable periods after the first few months. Minor skin changes or contact lens discomfort may occur.
Serious but uncommon effects include blood clots in the legs or lungs, stroke, heart attack, significant increases in blood pressure, gallbladder disease, liver problems (upper‑right abdominal pain, yellowing of skin/eyes), severe headaches or migraines, and vision changes. Seek immediate medical attention for symptoms of clotting (leg swelling/pain, chest pain, sudden shortness of breath), neurologic symptoms, or severe abdominal pain. If bleeding becomes heavy or prolonged, or you miss periods after taking pills correctly, consult your clinician to rule out pregnancy or other causes.
Some medicines can lower contraceptive hormone levels and reduce Mircette’s effectiveness, notably enzyme inducers such as rifampin/rifabutin, certain antiseizure drugs (carbamazepine, phenytoin, phenobarbital, primidone, topiramate at higher doses, oxcarbazepine), and some antiretrovirals. St. John’s wort is a common herbal inducer—avoid it. If use is unavoidable, employ a reliable backup method during therapy and for at least 7–28 days after, depending on the agent; ask your pharmacist for a personalized plan.
Estrogens can decrease lamotrigine levels, potentially worsening seizure control; lamotrigine dose adjustments may be required. Coadministration with certain hepatitis C antivirals (ombitasvir/paritaprevir/ritonavir ± dasabuvir) is not recommended due to liver enzyme elevations. Some antibiotics do not significantly impact COCs, but rifamycins do. Bile acid sequestrants may reduce hormone absorption; separate dosing times. Always provide a complete medication and supplement list to your healthcare professional.
If you miss 1 active Mircette pill by less than 24 hours, take it as soon as you remember and take the next dose at your regular time (you may take two pills in one day). No backup contraception is needed. If you miss 2 or more active pills (≥48 hours since a pill should have been taken), take the most recent missed pill ASAP, discard other missed pills, continue 1 pill daily, and use condoms for the next 7 days.
If the missed active pills occurred during the last week of active tablets (days 15–21), finish the current active pills and skip the 2 inert and 5 very low‑dose estrogen tablets—start a new pack the next day to avoid a hormone‑free interval. If you missed any of the last 7 tablets (the 2 placebo or the 5 low‑dose estrogen tablets), take the next pill when remembered and continue; backup is generally not required.
If you missed 2+ active pills in week 1 and had unprotected sex in the past 5 days, consider emergency contraception. If you miss pills and then miss a withdrawal bleed or have unusual bleeding, take a pregnancy test and consult your clinician. When in doubt, follow the package insert for Mircette/Kariva or ask a pharmacist for exact, product‑specific guidance.
Overdose symptoms may include nausea, vomiting, and withdrawal bleeding. There is no antidote; treatment is supportive. Contact Poison Control or seek medical care if a child or non‑user ingests multiple tablets or if severe symptoms occur.
Store Mircette at room temperature (68–77°F; 20–25°C), in the original blister to protect from moisture and light. Keep out of reach of children and pets. Do not store in bathrooms with excess humidity, and do not freeze. Check expiration dates and dispose of unused medication according to pharmacy guidance.
In the United States, desogestrel/ethinyl estradiol combination pills like Mircette are prescription medications. HealthSouth Hospital of Gadsden offers a legal and structured solution for people who do not have a current prescription by connecting you with a brief online health questionnaire reviewed by a licensed clinician. When appropriate, a valid prescription is issued and your medication is dispensed and shipped discreetly. Where regulations require, services are limited to eligible states and ages.
This streamlined process allows you to buy Mircette without prescription on hand while still meeting medical and regulatory standards. You receive pharmacist counseling, transparent pricing, automatic refill reminders, and access to FDA‑approved generic equivalents (such as Kariva, Azurette, or Viorele) if the Mircette brand is unavailable. Clinical review screens for contraindications to ensure safe use; if Mircette isn’t suitable, you’ll be advised on alternatives.
Note: Always provide an accurate medical history and full medication list during the assessment. Availability, coverage, and shipping times vary by location. This content is informational; consult a healthcare professional for individualized medical advice.
Mircette is a combined oral contraceptive pill containing desogestrel and ethinyl estradiol. It prevents pregnancy by suppressing ovulation, thickening cervical mucus, and thinning the uterine lining. The 28‑day pack typically has 21 active pills (desogestrel/ethinyl estradiol), 2 ethinyl estradiol–only pills, and 5 inactive pills.
With typical use, effectiveness is about 93%; with perfect use it exceeds 99%. It does not protect against sexually transmitted infections, so use condoms for STI protection.
Avoid Mircette if you have a history of blood clots, certain heart or liver diseases, breast cancer, migraine with aura, uncontrolled hypertension, or if you smoke and are over 35. Always review your personal risks with a clinician before starting.
You can do a Day 1 start (start on the first day of your period, no backup needed), a Sunday start (start the first Sunday after your period begins; use backup for 7 days), or a quick start (start today; use backup for 7 days). Confirm the plan with your prescriber.
If you miss one active pill (less than 48 hours late), take it as soon as you remember and continue the pack; no backup is needed. If you miss two or more active pills (48 hours or more), take the most recent missed pill now, discard others, continue the pack, and use backup for 7 days; if the miss occurs in week 1 and you had sex, consider emergency contraception.
If you vomit within about 2 hours of a dose, take another pill as soon as possible. If vomiting or severe diarrhea lasts more than 48 hours, continue taking pills but use backup contraception during the illness and for 7 days after recovery.
Nausea, breast tenderness, mild headache, spotting or breakthrough bleeding, and mood changes are the most common, especially in the first 2–3 packs. These often improve with time; persistent or severe symptoms warrant a check‑in with your clinician.
Combined pills slightly raise the risk of blood clots, stroke, and heart attack, especially in smokers over 35 or those with certain conditions. Seek urgent care for leg swelling/pain, chest pain, severe headache, vision changes, or shortness of breath.
Most users have lighter, more regular, and less painful periods. The two ethinyl estradiol–only pills may reduce hormone‑withdrawal headaches and other symptoms during the pill‑free interval; some spotting can occur in the first few cycles.
Significant weight gain is uncommon with low‑dose combined pills. Small, temporary fluid shifts can happen; consistent nutrition and activity help stabilize weight.
Desogestrel is relatively low‑androgenic, and the estrogen component can reduce sebum, so some users see less acne. Results vary; if acne persists, your clinician can suggest alternatives with acne indications.
Combined pills are generally avoided until at least 3–6 weeks postpartum due to clot risk and potential impact on milk supply. Progestin‑only methods are usually preferred early in breastfeeding.
Enzyme inducers can lower effectiveness, including rifampin/rifabutin, certain anti‑seizure drugs (e.g., carbamazepine, phenytoin, topiramate at higher doses), some HIV/HCV therapies, and St. John’s wort; modafinil may also interfere. Most antibiotics do not reduce pill efficacy except rifamycins; always review your medication list with a pharmacist or clinician.
Yes. To minimize bleeding, skip the two ethinyl estradiol–only and the five inactive pills and start a new pack after the 21 active pills. Some spotting may occur initially; confirm a continuous‑use plan with your prescriber.
Long flights and immobility increase clot risk; move frequently, hydrate, and consider compression socks on flights. For major surgery with prolonged immobilization, your surgeon may advise stopping combined pills about 4 weeks beforehand.
Availability of the brand varies by market, but equivalent generics are widely available (e.g., Kariva, Azurette, Viorele). These contain the same active ingredients and dosing schedule.
If you are over 35 and smoke, combined pills like Mircette are not recommended due to higher cardiovascular risk. If you are under 35, discuss risks and cessation support with your clinician.
No. Use dedicated emergency contraception (levonorgestrel or ulipristal) if needed; then follow specific guidance on when to resume or continue your pills and whether backup is needed.
Keep it at room temperature away from moisture and heat, and leave pills in the original blister until use. Check expiration dates before starting a new pack.
Mircette and Kariva have the same formulation: desogestrel 0.15 mg/ethinyl estradiol 0.02 mg for 21 days, then two 0.01 mg ethinyl estradiol pills and five inactive pills. They are clinically interchangeable; differences are brand, packaging, and price.
Azurette is a generic equivalent of Mircette with the same hormones and schedule. Expect the same effectiveness, side effect profile, and cycle control.
Viorele matches Mircette’s active ingredients and dosing pattern. Choice typically depends on pharmacy availability, insurance coverage, and cost.
Both contain desogestrel, but Apri pairs it with a higher estrogen dose (ethinyl estradiol 0.03 mg vs Mircette’s 0.02 mg). Apri may offer slightly fewer breakthrough bleeds but can have more estrogen‑related side effects like nausea or breast tenderness.
Desogen‑type products use desogestrel 0.15 mg with 0.03 mg ethinyl estradiol, while Mircette uses 0.02 mg plus two low‑dose EE days. Mircette’s lower estrogen may reduce estrogenic side effects; Desogen’s higher estrogen may provide tighter cycle control for some users.
Yaz contains drospirenone/ethinyl estradiol (20 mcg) and is approved for acne and PMDD; drospirenone has antimineralocorticoid effects that can help bloating but requires caution with potassium‑raising drugs. Mircette uses desogestrel, which is low‑androgenic; both are effective, but side‑effect profiles differ.
Yasmin has drospirenone with 30 mcg ethinyl estradiol, offering higher estrogen exposure than Mircette. Yasmin may help acne and fluid retention but may have more estrogen‑related side effects; Mircette’s lower estrogen often means lighter menses and fewer estrogenic symptoms.
Loestrin/Junel products use norethindrone (or norethindrone acetate) with varying estrogen doses. Compared with Mircette’s desogestrel, norethindrone can be slightly more androgenic, which may affect acne or mood for some; individual response varies.
Mircette is essentially monophasic for 21 days, while Ortho Tri‑Cyclen changes progestin dose across the cycle (triphasic) and is FDA‑approved for acne. Some prefer monophasic pills for stable hormones; others like triphasic for cycle control—both are similarly effective.
Lo Loestrin Fe has very low estrogen (10 mcg most days), which may reduce estrogenic side effects but often causes more breakthrough bleeding. Mircette’s 20 mcg estrogen plus two low‑dose EE pills may balance bleeding control and side effects for many users.
Seasonale/Seasonique are extended‑cycle combined pills designed for 4 periods per year (or none with continuous use), but early breakthrough bleeding is common. Mircette follows a monthly cycle; you can also run Mircette packs back‑to‑back to reduce bleeding frequency if desired.
Sprintec (norgestimate/ethinyl estradiol 35 mcg) has higher estrogen than Mircette’s 20 mcg. Higher estrogen may reduce spotting but can increase nausea, breast tenderness, and headache; progestin type also differs, which can influence acne and mood.